19.11.2012 Views

Book of Abstracts - Ruhr-Universität Bochum

Book of Abstracts - Ruhr-Universität Bochum

Book of Abstracts - Ruhr-Universität Bochum

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P-73<br />

ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />

Asborin Meets Titanium<br />

Matthias Scholz a and Evamarie Hey-Hawkins* a<br />

a <strong>Universität</strong> Leipzig, Institute <strong>of</strong> Inorganic Chemistry, Johannisallee 29, D-04103 Leipzig, Germany,<br />

E-mail: mscholz@chemie.uni-leipzig.de<br />

Asborin, the carbaborane analogue <strong>of</strong> aspirin ® , is one <strong>of</strong> the few examples in which carbaboranes are<br />

used as phenyl-mimetic pharmacophores. Asborin was synthesised in a high-yield procedure starting<br />

from ortho-carbaborane. The compound proved to inhibit both cyclooxygenase (COX) isozymes, the<br />

target enzymes <strong>of</strong> aspirin. 1 The COX inhibition potential, however, was lower compared to aspirin and<br />

the general pharmacological pr<strong>of</strong>ile was also different to that <strong>of</strong> aspirin. Integration <strong>of</strong> the cluster in<br />

place <strong>of</strong> the phenyl ring turned aspirin into a more toxic compound, which triggers apoptosis<br />

pathways. Asborin was cytotoxic toward several cancer cell lines and exhibited the lowest potency<br />

toward healthy fibroblasts. This behaviour made the carbaborane compound interesting for anticancer<br />

drug development. As the IC50 values obtained from the cytotoxicity assays were higher than those <strong>of</strong><br />

commercial chemotherapeutic agents, the compound requires further fine-tuning <strong>of</strong> its cytotoxic<br />

pr<strong>of</strong>ile.<br />

A promising approach to increase the antitumour activity <strong>of</strong> asborin is combination with another<br />

cytotoxic moiety. Therefore, we decided to modify asborin with titanium complexes, as some<br />

derivatives were found to be active toward several tumour cells. The most prominent anticancer<br />

titanium derivatives are the organometallic compound titanocene dichloride and the bioinorganic<br />

complex budotitane. 2 The carboxyl group and carbaborane moiety <strong>of</strong> asborin allow it to form both<br />

bioinorganic and organometallic titanium compounds. Coordination <strong>of</strong> asborin as carboxylate could<br />

displace the chloride ions in titanocene dichloride. Alternatively, instead <strong>of</strong> a cyclopentadienyl ring the<br />

nido carbaborane cluster can act as ligand for titanium. Thus, carbaboranes can easily be deboronated<br />

to give anionic nido clusters, which feature an open pentagonal plane. These anions can then form<br />

different metallocene analogues.<br />

References<br />

1. M. Scholz, K. Bensdorf, R. Gust, E. Hey-Hawkins, ChemMedChem. 2009, 4, 746-748.<br />

2. J. C. Dabrowiak: Titanium compounds for treating cancer in Metals in Medicine; 1. Ed.; Wiley:<br />

New York, USA, 2009; pp. 167-177.<br />

131

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!